Overview

* Brookdale Q2 Adjusted EBITDA rises 19.7%, beating analyst expectations, per LSEG data

* Company raises annual guidance for RevPAR and Adjusted EBITDA

* Net loss widens to $43 mln due to higher operating expenses

Outlook

* Brookdale raises full-year 2025 RevPAR growth guidance to 5.25%-6.00%

* Company increases 2025 Adjusted EBITDA guidance to $445 mln-$455 mln

* Brookdale expects positive Adjusted Free Cash Flow of $30 mln-$50 mln for 2025

Result Drivers

* OCCUPANCY INCREASE - Weighted average occupancy rose to 80.1%, driving higher resident fees

* EXPENSES - Facility operating expenses increased due to higher wage rates and maintenance costs

* RESTRUCTURING COSTS - General and administrative expenses rose due to transaction and restructuring costs

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Net -$43 mln

Income

Q2 Beat $117.10 $115.20

Adjusted mln mln (5

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy."

* Wall Street's median 12-month price target for Brookdale Senior Living Inc ( BKD ) is $7.75, about 1.7% below its August 5 closing price of $7.88

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)